Clinical Trials Directory

Trials / Active Not Recruiting

Active Not RecruitingNCT06109662

Multimorbidity and Sarcopenia Feasibility Study in Chronic Kidney Disease

Status
Active Not Recruiting
Phase
Study type
Observational
Enrollment
80 (estimated)
Sponsor
University Hospitals of Derby and Burton NHS Foundation Trust · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Accepted

Summary

The aim of this research study is to look at the body composition (such as muscle and fat) in people with chronic kidney disease (CKD) and comparing it with body composition is people without CKD. The investigators currently understand loss of muscle function and mass (sarcopenia) affect the general health of people as they age, but this process seems to be more common, accelerated, and occurs earlier in people with CKD. There is limited evidence in this area, and we believe that if we understand when and how sarcopenia affects people with CKD, investigators can guide future trials and treatments to help treat sarcopenia, and in turn improve quality of life and health outcomes in people with CKD.

Detailed description

In this study, the investigators will follow up people with CKD in two visits a year apart. In both visits, the investigators will measure the participants body composition and estimated kidney function using 2 different testing methods - Cystatin C eGFR and Creatinine eGFR. Using both the results in a formula, the creatinine muscle index can be calculated. If this index correlated with sarcopenia, it will be helpful tool in the care of people with CKD as will be a easy to use screening tool for sarcopenia in this population.

Conditions

Interventions

TypeNameDescription
DIAGNOSTIC_TESTCystatin C eGFRCystatin C eGFR is not used routinely currently in clinical practice in the UK. It involved a blood test to analyse Cystatin C.
OTHERBioimpedance Analysis (Body composition analysis)Participants will stand on a bioimpedance analysis machine which will measure different components of body composition

Timeline

Start date
2024-02-12
Primary completion
2025-11-02
Completion
2025-11-02
First posted
2023-10-31
Last updated
2025-09-05

Locations

1 site across 1 country: United Kingdom

Source: ClinicalTrials.gov record NCT06109662. Inclusion in this directory is not an endorsement.